Skip to main content

Table 1 Summary of antibodies used in this study

From: The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells

Antibodies

Purchase order number

Supplier

EGFR, rabbit mAb, clone C74B9

#2646

CSTa

Phospho-EGFR Tyr992, rabbit polyclonal

#2235

CSTa

HER2/ErbB2, rabbit mAB, clone 29D8

#2165

CSTa

Phospho-HER2/ErbB2 Tyr1196, rabbit mAb, clone D66B7

#6942

CSTa

AKT (pan), rabbit mAb, clone 11E7

#4685

CSTa

Phospho-AKT Ser473, rabbit mAb, clone D9E

#4060

CSTa

p44/42 MAPK (ERK1/2), rabbit polyclonal

#9102

CSTa

Phospho-p44/42 (ERK1/2) Thr202/Tyr204, rabbit polyclonal

#9101

CSTa

PLC-γ1, rabbit mAb, clone D9H10

#5690

CSTa

Phospho-PLC-γ1 Tyr783, rabbit mAb, clone D6M9S

#14008

CSTa

PLD1, rabbit polyclonal

#3832

CSTa

PLD1, rabbit monoclonal, clone EP1506Y

ab68150

Abcamb

Sigma-1-receptor, mouse mAb, clone B-5

sc-137075

Santa Cruzc

elf4E, rabbit polyclonal

#9742

CSTa

β-actin, rabbit mAb, clone 13E5

#4970

CSTa

rabbit IgG

sc3888

Santa Cruzc

Anti-mouse-IgG-HRP-linked

#7076

CSTa

Anti-rabbit-IgG-HRP-linked

#7074

CSTa

  1. aCell Signaling Technology Europe, Frankfurt am Main, Germany
  2. bAbcam, Berlin, Germany
  3. cSanta Cruz Biotechnology Inc., Heidelberg, Germany